SI1107795T1 - Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis - Google Patents
Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritisInfo
- Publication number
- SI1107795T1 SI1107795T1 SI9930205T SI9930205T SI1107795T1 SI 1107795 T1 SI1107795 T1 SI 1107795T1 SI 9930205 T SI9930205 T SI 9930205T SI 9930205 T SI9930205 T SI 9930205T SI 1107795 T1 SI1107795 T1 SI 1107795T1
- Authority
- SI
- Slovenia
- Prior art keywords
- thiomolybdate
- carbohydrate
- cancer
- preventing
- rheumatoid arthritis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9910398P | 1998-09-04 | 1998-09-04 | |
US10175998P | 1998-09-25 | 1998-09-25 | |
EP99952903A EP1107795B1 (fr) | 1998-09-04 | 1999-09-03 | Thiomolybdate associe a au moins un hydrate de carbone, et son utilisation dans la prevention et le traitement de maladies caracterisees par une vascularisation anormale, telles que le cancer, la degenerescence maculaire de type exsudatif, l'arthrite rhumatoide |
PCT/US1999/020374 WO2000013712A2 (fr) | 1998-09-04 | 1999-09-03 | Methodes et compositions pour la prevention ou le traitement du cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1107795T1 true SI1107795T1 (en) | 2003-06-30 |
Family
ID=27240352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9930205T SI1107795T1 (en) | 1998-09-04 | 1999-09-03 | Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1234585A3 (fr) |
SI (1) | SI1107795T1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6703050B1 (en) | 1998-09-04 | 2004-03-09 | The Regents Of The University Of Michigan | Methods and compositions for the prevention or treatment of cancer |
WO2000018392A1 (fr) | 1998-09-25 | 2000-04-06 | Glycox Corporation Limited | Fructosamine-oxydase: antagonistes et inhibiteurs |
AU2003225442B2 (en) | 2002-03-08 | 2010-02-04 | Philera New Zealand Limited | Preventing and/or treating cardiovascular disease and/or associated heart failure |
US7888389B2 (en) | 2002-07-23 | 2011-02-15 | The Regents Of The University Of Michigan | Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
WO2004017956A1 (fr) * | 2002-08-20 | 2004-03-04 | Protemix Corporation Limited | Formes posologiques et traitements s'y rapportant |
AU2005281353A1 (en) | 2004-07-19 | 2006-03-16 | Philera New Zealand Limited | Synthesis of triethylenetetramines |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69230131T2 (de) | 1991-07-03 | 2000-03-02 | Otsuka Pharmaceutical Co., Ltd. | Apoptoseregulator |
US5464833A (en) | 1992-08-19 | 1995-11-07 | Otsuka Pharmaceutical Co., Ltd. | Apoptosis regulating composition |
NZ254646A (en) | 1992-08-19 | 1997-06-24 | Merrell Dow Pharma | Inhibition of angiogenesis by administration of a polyamide and a polyurea |
US5801029A (en) | 1993-02-16 | 1998-09-01 | Onyx Pharmaceuticals, Inc. | Cytopathic viruses for therapy and prophylaxis of neoplasia |
US5399586A (en) | 1993-03-11 | 1995-03-21 | Allergan, Inc. | Treatment of mammals afflicted with tumors with compounds having RXR retinoid receptor agonist activity |
NO941135L (no) | 1993-04-01 | 1994-10-03 | Daiichi Seiyaku Co | Tiazolpyrimidin derivater |
US5886026A (en) | 1993-07-19 | 1999-03-23 | Angiotech Pharmaceuticals Inc. | Anti-angiogenic compositions and methods of use |
US5504074A (en) | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
US5539094A (en) | 1993-11-12 | 1996-07-23 | La Jolla Cancer Research Foundation | DNA encoding Bcl-2-associated proteins |
US5622829A (en) | 1993-12-08 | 1997-04-22 | The Regents Of The University Of California | Genetic markers for breast, ovarian, and prostatic cancer |
GB9326136D0 (en) | 1993-12-22 | 1994-02-23 | Erba Carlo Spa | Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents |
US5565491A (en) | 1994-01-31 | 1996-10-15 | Bristol-Myers Squibb Company | Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation |
US5583034A (en) | 1994-02-22 | 1996-12-10 | La Jolla Institute For Allergy And Immunology | Enhancement of adoptosis using antisense oligonucleotides |
US5591717A (en) | 1994-04-06 | 1997-01-07 | Rojko; Jennifer L. | Branched apogenic peptide for inducing apoptosis |
US5639725A (en) | 1994-04-26 | 1997-06-17 | Children's Hospital Medical Center Corp. | Angiostatin protein |
US5618925A (en) | 1994-04-28 | 1997-04-08 | Les Laboratories Aeterna Inc. | Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
US5605826A (en) | 1994-06-10 | 1997-02-25 | Panorama Research, Inc. | 24 kilodalton cytoplasmic protease activating DNA fragmentation in apoptosis |
US5693473A (en) | 1994-08-12 | 1997-12-02 | Myriad Genetics, Inc. | Linked breast and ovarian cancer susceptibility gene |
US5710001A (en) | 1994-08-12 | 1998-01-20 | Myriad Genetics, Inc. | 17q-linked breast and ovarian cancer susceptibility gene |
US5709999A (en) | 1994-08-12 | 1998-01-20 | Myriad Genetics Inc. | Linked breast and ovarian cancer susceptibility gene |
US5587459A (en) | 1994-08-19 | 1996-12-24 | Regents Of The University Of Minnesota | Immunoconjugates comprising tyrosine kinase inhibitors |
US5571523A (en) | 1995-03-09 | 1996-11-05 | President And Fellows Of Harvard College | Antioxidant-induced apoptosis in vascular smooth muscle cells |
US5654155A (en) | 1996-02-12 | 1997-08-05 | Oncormed, Inc. | Consensus sequence of the human BRCA1 gene |
-
1999
- 1999-09-03 SI SI9930205T patent/SI1107795T1/xx unknown
- 1999-09-03 EP EP02011198A patent/EP1234585A3/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1234585A3 (fr) | 2004-01-21 |
EP1234585A2 (fr) | 2002-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA988572B (en) | Narrow MWD, compositionally optimized ethylene interpolymer composition, process for making the same and article made therefrom. | |
AU8749198A (en) | Deodorant and antimicrobial water absorbent, process for the production thereof and absorbent articles | |
ZA200005329B (en) | Organic Articles. | |
ZA200201511B (en) | 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents. | |
EP0685233A3 (fr) | Thieno 1,5 benzodiazepine pour le traitement des troubles gastrointestinaux. | |
ZA200108530B (en) | 4,5,6,7-tetrahydroindazole derivatives as antitumor agents. | |
ZA991664B (en) | 3,6-ketal and enol ether macrolide antibiotics. | |
ZA200107910B (en) | Sizing composition. | |
ZA984647B (en) | Dextran production. | |
EP0664516A3 (fr) | Réseau neuronal avec quantité de calcul réduite. | |
CY2425B1 (en) | 2,4-Diaminopyrimidine derivatives. | |
MXPA00007394A (es) | Compuestos, composiciones y metodos para tratar o evitar infeccion de neumovirus y enfermedades asociadas. | |
SI1107795T1 (en) | Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis | |
HK1051533A1 (en) | Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use. | |
PL348036A1 (en) | Tissue paper product, and process for making the product | |
ZA200109607B (en) | Treated closures 3. | |
ZA9710070B (en) | Refundable travellers cheques. | |
ZA200109605B (en) | Treated closures 2. | |
GB2336347B (en) | Roller conveyor or roller conveyor section | |
ZA200101188B (en) | DNAzymes and methods for treating restenosis. | |
ZA997525B (en) | Conveyor belting with modified fabric. | |
ZA972302B (en) | 1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives. | |
SG43383A1 (en) | N n-diethyl-8,8-dipropyl-2-azaspiro[4.5]decane-2- propanamine dimaleate | |
Peter | Johnson | |
EP0653438A3 (fr) | Composés oligonucléotidiques, leur production et leur utilisation. |